Title : Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.

Pub. Date : 2018 Jan-Mar

PMID : 29516929






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The proportion of TOP2A-positive cancer cells was significantly higher among anthracycline responders than among nonresponders in HR-negative cancer (15.4% +-17.5% vs. 2.0% +- 2.4%, respectively, P = 0.048), whereas TOP2A and TIMP-1 expression statuses did not differ in HR-positive cancer. Anthracyclines DNA topoisomerase II alpha Homo sapiens
2 The proportion of TOP2A-positive cancer cells was significantly higher among anthracycline responders than among nonresponders in HR-negative cancer (15.4% +-17.5% vs. 2.0% +- 2.4%, respectively, P = 0.048), whereas TOP2A and TIMP-1 expression statuses did not differ in HR-positive cancer. Anthracyclines DNA topoisomerase II alpha Homo sapiens
3 Anthracycline responders showed a trend to have a higher proportion of patients with either >=5% TOP2A-positive cancer cells or <=20% TIMP-1-positive cancer cells compared to nonresponders (86.7% vs. 61.5%, respectively, P = 0.066). Anthracyclines DNA topoisomerase II alpha Homo sapiens